These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20813184)

  • 21. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H
    Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal transduction in prostate cancer progression.
    Gioeli D
    Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
    Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
    Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of androgen receptor signaling in prostate cancer.
    Dehm SM; Tindall DJ
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
    Xie S; Lin HK; Ni J; Yang L; Wang L; di Sant'Agnese PA; Chang C
    Prostate; 2004 Jun; 60(1):61-7. PubMed ID: 15129430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C; Kim RS; Zhang HJ; Lee SJ; Jeng MH
    Cancer Res; 2004 Dec; 64(24):9185-92. PubMed ID: 15604291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coupling of cAMP/PKA and MAPK signaling in neuronal cells is dependent on developmental stage.
    Vogt Weisenhorn DM; Roback LJ; Kwon JH; Wainer BH
    Exp Neurol; 2001 May; 169(1):44-55. PubMed ID: 11312557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C.
    Ren J; Karpinski E; Benishin CG
    J Pharmacol Exp Ther; 1996 Apr; 277(1):394-402. PubMed ID: 8613946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The androgen receptor: a potential target for therapy of prostate cancer.
    Santos AF; Huang H; Tindall DJ
    Steroids; 2004 Feb; 69(2):79-85. PubMed ID: 15013685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS
    Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
    Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM
    Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
    Manna PR; Chandrala SP; Jo Y; Stocco DM
    J Mol Endocrinol; 2006 Aug; 37(1):81-95. PubMed ID: 16901926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyk2 and Cyr61 at the cross-road of cAMP-dependent signalling in invasiveness and neuroendocrine differentiation of prostate cancer.
    Vitale G; Gentilini D; Abbruzzese A; Caraglia M
    Cancer Biol Ther; 2009 Feb; 8(3):243-4. PubMed ID: 19182531
    [No Abstract]   [Full Text] [Related]  

  • 35. Androgen receptor activation by G(s) signaling in prostate cancer cells.
    Kasbohm EA; Guo R; Yowell CW; Bagchi G; Kelly P; Arora P; Casey PJ; Daaka Y
    J Biol Chem; 2005 Mar; 280(12):11583-9. PubMed ID: 15653681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptors in prostate and skeletal muscle.
    Tindall DJ
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S26-30; discussion S30-1. PubMed ID: 10959212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells.
    Bagchi G; Wu J; French J; Kim J; Moniri NH; Daaka Y
    Cancer Res; 2008 May; 68(9):3225-31. PubMed ID: 18451148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.
    Pernicová Z; Slabáková E; Fedr R; Šimečková Š; Jaroš J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A; Souček K
    Mol Cancer; 2014 May; 13():113. PubMed ID: 24884804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgens and androgen receptor in prostate and ovarian malignancies.
    Meehan KL; Sadar MD
    Front Biosci; 2003 May; 8():d780-800. PubMed ID: 12700055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.
    Jones SE; Palmer TM
    Cell Signal; 2012 Aug; 24(8):1504-14. PubMed ID: 22504159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.